CATSPER3: A Potential Drug Target and Biomarker (G347732)

Target Name: CATSPER3

NCBI ID: G347732

CATSPER3

CATSPER3: A Potential Drug Target and Biomarker

CATSPER3, or cathelic acid-like protein 3, is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study, and its potential as a drug or biomarker has led to a growing interest in the field of neurodegenerative diseases.

The protein CATSPER3 is composed of 254 amino acids and has a calculated molecular weight of 31.1 kDa. It is localized to the endoplasmic reticulum (ER) and is predominantly expressed in the brain, heart, and kidneys. Its function is not well understood, but studies have shown that it is involved in various physiological processes, including cell signaling, neurotransmitter release, and stress response.

One of the key features of CATSPER3 is its ability to interact with various signaling molecules, including G protein-coupled receptors (GPCRs) and ion channels. This interaction allows CATSPER3 to regulate a wide range of physiological processes, including neuronal excitability, synaptic plasticity, and inflammation. As a result, CATSPER3 has been shown to play a role in various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and epilepsy.

In addition to its role in neurological disorders, CATSPER3 has also been shown to be involved in diseases of the eye and respiratory system. For example, studies have shown that CATSPER3 is involved in the development and progression of age-related macular degeneration (AMD), a leading cause of blindness in the elderly. CATSPER3 has also been shown to be involved in the regulation of eye movements and in the development of chronic dry eye, which is a common complication in patients with AMD.

Another study has shown that CATSPER3 is involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease. The researchers found that CATSPER3 was expressed in the brains of individuals with Alzheimer's disease and that its levels were decreased in the brains of individuals with the disease compared to age-matched controls. The study suggests that CATSPER3 may be a potential biomarker for Alzheimer's disease and that it may be a target for future therapeutic interventions.

In addition to its potential as a drug target, CATSPER3 has also been shown to be a potential biomarker for various diseases. For example, studies have shown that CATSPER3 is involved in the regulation of pain perception and that its levels are decreased in individuals with chronic pain. The researchers found that CATSPER3 may be a potential target for pain medications and that its levels were decreased in individuals with chronic pain compared to age-matched controls.

CATSPER3 has also been shown to be involved in the regulation of inflammation and has been shown to have anti-inflammatory effects. Studies have shown that CATSPER3 can inhibit the production of pro-inflammatory cytokines, such as TNF-alpha, and can reduce the expression of adhesion molecules on immune cells. This suggests that CATSPER3 may be a potential target for anti-inflammatory therapies.

In conclusion, CATSPER3 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to study, and its potential as a drug or biomarker has led to a growing interest in the field of neurodegenerative diseases. Further research is needed to fully understand the role of CATSPER3 in disease and to develop safe and effective therapies that target this protein.

Protein Name: Cation Channel Sperm Associated 3

Functions: Voltage-gated calcium channel that plays a central role in calcium-dependent physiological responses essential for successful fertilization, such as sperm hyperactivation, acrosome reaction and chemotaxis towards the oocyte

The "CATSPER3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CATSPER3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets